Host range, amplification and arboviral disease emergence
Author:
- 1 January 2005
- book chapter
- Published by Springer Nature
- No. 19,p. 33-44
Abstract
Etiologic agents of arboviral diseases are primarily zoonotic pathogens that are maintained in nature in cycles involving arthropod transmission among a variety of susceptible reservoir hosts. In the simplest form of human exposure, spillover occurs from the enzootic cycle when humans enter zoonotic foci and/or enzootic amplification increases circulation near humans. Examples include Eastern (EEEV) and Western equine encephalitis viruses (WEEV), as well as West Nile (WNV), St. Louis encephalitis (SLEV) and Yellow fever viruses. Spillover can involve direct transmission to humans by primary enzootic vectors (e.g. WNV, SLEV and WEEV) and/or bridge vectors with more catholic feeding preferences that include humans (e.g. EEEV). Some viruses, such as Rift Valley fever, Japanese encephalitis and Venezuelan equine encephalitis viruses (VEEV) undergo secondary amplification involving replication in livestock animals, resulting in greater levels of spillover to humans in rural settings. In the case of VEEV, secondary amplification involves equines and requires adaptive mutations in enzootic strains that allow for efficient viremia production. Two of the most important human arboviral pathogens, Yellow fever and dengue viruses (DENV), have gone one step further and adopted humans as their amplification hosts, allowing for urban disease. The ancestral forms of DENV, sylvatic viruses transmitted among nonhuman primate reservoir hosts by arboreal mosquitoes, adapted to efficiently infect the urban mosquito vectors Aedes aegypti and Ae. albopictus during the past few thousand years as civilizations arose. Comparative studies of the sylvatic and urban forms of DENV may elucidate the evolution of arboviral virulence and the prospects for DENV eradication should effective vaccines be implemented.Keywords
This publication has 22 references indexed in Scilit:
- Envelope Glycoprotein Mutations Mediate Equine Amplification and Virulence of Epizootic Venezuelan Equine Encephalitis VirusJournal of Virology, 2005
- Dengue Emergence and Adaptation to Peridomestic MosquitoesEmerging Infectious Diseases, 2004
- Venezuelan equine encephalitis emergence: Enhanced vector infection from a single amino acid substitution in the envelope glycoproteinProceedings of the National Academy of Sciences, 2004
- Rift Valley Fever Epidemic in Saudi Arabia: Epidemiological, Clinical, and Laboratory CharacteristicsClinical Infectious Diseases, 2003
- Experimental Infection of North American Birds with the New York 1999 Strain of West Nile VirusEmerging Infectious Diseases, 2003
- Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.Proceedings of the National Academy of Sciences, 1995
- Genetic evidence that epizootic Venezuelan equine encephalitis (VEE) viruses may have evolved from enzootic VEE subtype I-D virusVirology, 1992
- Genetic Variation of Venezuelan Equine Encephalitis Virus Strains of the ID Variety in ColombiaThe American Journal of Tropical Medicine and Hygiene, 1988
- Genetics and the Origin of a Vector Population: Aedes aegypti , a Case StudyScience, 1980
- Isolement du virus de la dengue au SénégalAnnales de l'Institut Pasteur / Virologie, 1980